Results 51 to 60 of about 2,986,927 (385)

Frailty in liver transplantation: An expert opinion statement from the American Society of Transplantation Liver and Intestinal Community of Practice

American Journal of Transplantation, 2019
Frailty has emerged as a powerful predictor of outcomes in patients with cirrhosis and has inevitably made its way into decision making within liver transplantation. In an effort to harmonize integration of the concept of frailty among transplant centers,
J. Lai, C. Sonnenday, E. Tapper, A. Duarte-Rojo, M. Dunn, W. Bernal, E. Carey, S. Dasarathy, B. Kamath, M. Kappus, A. Montaño-Loza, S. Nagai, P. Tandon   +12 more
semanticscholar   +1 more source

Long noncoding RNA CERS6-AS1 modulates glucose metabolism and tumor progression in hepatocellular carcinoma by promoting the MDM2/p53 signaling pathway

Cell Death Discovery, 2022
Hepatocellular carcinoma (HCC) is one of the most serious malignant cancers and has a high fatality rate. However, clinical strategies for the effective treatment of HCC remain lacking.
Bo Xu, Yonggang Wei, Fei Liu, Lian Li, Siqi Zhou, Yufu Peng, Bo Li   +6 more
doaj   +1 more source

Changes in the Prevalence of Hepatitis C Virus Infection, Nonalcoholic Steatohepatitis, and Alcoholic Liver Disease Among Patients With Cirrhosis or Liver Failure on the Waitlist for Liver Transplantation.

Gastroenterology, 2017
BACKGROUND & AIMS Concurrent to development of more effective drugs for treatment of hepatitis C virus (HCV) infection, there has been an increase in the incidence of nonalcoholic fatty liver disease.
D. Goldberg, I. Ditah, K. Saeian, M. Lalehzari, A. Aronsohn, E. Gorospe, M. Charlton   +6 more
semanticscholar   +1 more source

PCSK9 promotes tumor growth by inhibiting tumor cell apoptosis in hepatocellular carcinoma

Experimental Hematology & Oncology, 2021
Background Proprotein convertase subtilisin/kexin type 9 (PCSK9), one of the key enzymes in the process of lipid transport, is involved in the disease progression of various types of tumors.
Shi-Zhe Zhang, Xiao-Dong Zhu, Long-Hai Feng, Xiao-Long Li, Xue-Feng Liu, Hui-Chuan Sun, Zhao-You Tang   +6 more
doaj   +1 more source

Isohemagglutinins of Graft Origin after ABO-Unmatched Liver Transplantation [PDF]

, 1984
THE increasing success of liver transplantation in recent years has provided an experimental model to study and document the hepatic synthesis of many plasma proteins.12345 The normal hepatobiliary tract has not been regarded as a major source of ...
Anderson, Bird, Borel, Glenn Ramsey, Gwenn D. Lindsay, Jacob Nusbacher, Kukral, Lindsey, Lundgren, Marchioro, Rannie, Shaw, Starzl, Thomas E. Starzl   +13 more
core   +1 more source

Split Liver Transplantation and Pediatric Waitlist Mortality in the United States: Potential for Improvement

Transplantation, 2019
Background. In the United States, 1 in 10 infants and 1 in 20 older children die on the liver transplant waiting list. Increasing split liver transplantation could increase organ availability for these children, without decreasing transplants in adults ...
E. Perito, G. Roll, J. Dodge, S. Rhee, J. Roberts   +4 more
semanticscholar   +1 more source

Successful orthotopic liver transplantation in an adult patient with sickle cell disease and review of the literature [PDF]

, 2013
Sickle cell disease can lead to hepatic complications ranging from acute hepatic crises to chronic liver disease including intrahepatic cholestasis, and iron overload.
Blinder, Morey A., Chapman, William, Crippin, Jeffrey S., Field, Joshua J., Geng, B., Korenblat, Kevin, Lisker-Melman, Mauricio, Shenoy, Shalini   +7 more
core   +2 more sources

Minimizing Incision in Living Donor Liver Transplantation: Initial Experience and Comparative Analysis of Upper Midline Incision in 115 Recipients

Transplant International
Living donor liver transplantation (LDLT) needs “Mercedes Benz” or “J-shaped” incision, causing short and long-term complications. An upper midline incision (UMI) is less invasive alternative but technically challenging.
Amit Rastogi, Ankur A. Gupta, Raghav Bansal, Fysal Kollanta Valappil, Kamal S. Yadav, Suchet Chaudhary, Prashant Bhangui, Swapnil Dhampalvar, Narendra S. Choudhary, Neeraj Saraf, Arvinder S. Soin   +10 more
doaj   +1 more source

Whole-genome sequencing reveals the evolutionary trajectory of HBV-related hepatocellular carcinoma early recurrence

Signal Transduction and Targeted Therapy, 2022
Patients with hepatocellular carcinoma (HCC) have poor long-term survival following curative resection because of the high rate of tumor early recurrence. Little is known about the trajectory of genomic evolution from primary to early-recurrent HCC.
Shao-Lai Zhou, Zheng-Jun Zhou, Cheng-Li Song, Hao-Yang Xin, Zhi-Qiang Hu, Chu-Bin Luo, Yi-Jie Luo, Jia Li, Zhi Dai, Xin-Rong Yang, Ying-Hong Shi, Zheng Wang, Xiao-Wu Huang, Jia Fan, Jian Zhou   +14 more
doaj   +1 more source

Liver transplantation for hepatitis C virus (HCV) non‐viremic recipients with HCV viremic donors

American Journal of Transplantation, 2018
In the context of organ shortage, the opioid epidemic, and effective direct‐acting antiviral (DAA) therapy for hepatitis C virus (HCV), more HCV‐infected donor organs may be used for liver transplantation.
A. Kwong, A. Wall, M. Melcher, U. Wang, Aijaz Ahmed, A. Subramanian, P. Kwo   +6 more
semanticscholar   +1 more source